Previous close | 12.00 |
Open | 12.64 |
Bid | 11.10 |
Ask | 13.70 |
Strike | 40.00 |
Expiry date | 2025-03-21 |
Day's range | 12.00 - 12.64 |
Contract range | N/A |
Volume | |
Open interest | 389 |
Novavax stock popped Friday on news of a licensing deal and minority stake from Big Pharma player Sanofi.
As the big drugmaker tries to turn its fortunes around by focusing on oncology, it has turned to a Citi analyst who hasn’t recommended the stock in over a decade. But Andrew Baum has something Pfizer needs: oncology expertise.
Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Visa Inc. (V) and Pfizer Inc. (PFE).